Alexion at SCOPE 2027

Mar 1–4, 2027 Orlando, FL ~5k attendees Website

Alexion brings 5 presentations to SCOPE 2027 in Orlando. Its sessions center on rare disease trials, AI in clinical research and planning around biospecimens. One example uses AI-driven real-world data integration to build external control arms in ultra-rare diseases.

Organization	SCOPE 2027 Attendance
Alexion Boston, MA
alexion.com Large pharma AstraZeneca's rare disease unit, developing and marketing medicines for rare conditions.	Talk Tue Mar 2 12:20pm–12:45pm Closing the White Space in Fully Outsourced Clinical Trials: Using AI to Detect SOP Gaps, Clarify Accountability, and Strengthen Inspection Readiness Outsourcing Talk Tue Mar 2 3:05pm–3:30pm The Chain of Consent: Preserving Participant Intent to Enable Future Scientific Discovery Biospecimen Strategy & Operations Talk Tue Mar 2 3:30pm–3:55pm Beyond the Pilot: Making AI Work in Clinical Research AI in Clinical Research Talk Wed Mar 3 11:40am–12:05pm Bridging the Data Chasm: Using AI-Driven RWD Integration to Build External Control Arms in Ultra-Rare Diseases Plenary AI in clinical researchClinical data and real-world evidence Talk Thu Mar 4 9:25am–9:50am Designing Rare Disease Trials with Biospecimens in Mind Plenary Biospecimen strategy and operationsTrial design and delivery

Organization

SCOPE 2027 Attendance

Alexion

Boston, MA

alexion.com

Large pharma

AstraZeneca's rare disease unit, developing and marketing medicines for rare conditions.

Talk

Tue Mar 2
12:20pm–12:45pm

Closing the White Space in Fully Outsourced Clinical Trials: Using AI to Detect SOP Gaps, Clarify Accountability, and Strengthen Inspection Readiness

Outsourcing

Talk